Skip to main content

Cost-effective reimbursement analysis for medical technologies in Europe

Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 34 EU countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to better understand the potential scope of our support.

From the week of the 26th of August, we are planning to work on 19 projects, including:

Reimbursement

  1. Finalizing the reimbursement analysis for a neurostimulator in the cardiology field in England, France, Germany and Italy
  2. Finalizing the work on coding guides for physicians for technology in the cardiology field in England, Germany and Switzerland
  3. Finalizing the work on reimbursement analysis and strategy for in-vitro diagnostic test in the diabetes field in Belgium and Italy
  4. Working on the reimbursement analysis for an MRI technology in Germany
  5. Finalizing the work on reimbursement analysis for medical technology in the cardiology field in Denmark, Finland, Luxembourg, Norway, and Sweden
  6. Working on the reimbursement analysis project for four cardiology and peripheral vascular technologies in Italy and Poland
  7. Starting a policy analysis project, including qualitative interviews in the obstetrics and gynecology field in Austria, Denmark, Finland, Norway and Sweden 
  8. Developing an overview of payment mechanisms for hospital procedures and devices in Belgium, Denmark, England, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Spain, Sweden, and Switzerland
  9. Working on the reimbursement analysis for cardiac monitoring solutions in Finland
  10. Initiating the work on the reimbursement strategy for a number of in-vitro diagnostic tests in the obstetrics and gynecology field in Belgium, Bulgaria, the Czech Republic, France, Germany, Italy, Norway, Romania, and Switzerland
  11. Initiating the work on the reimbursement analysis for several technologies in ophthalmological, urological, and oncological fields in the Nordic region (Denmark, Finland, Norway, and Sweden)
  12. Initiating the work on reimbursement analysis for in-vitro diagnostic tests in the neonatal field in France and Italy

HEOR

  1. Finalizing the work on adaptations of the health economic model for in-vitro diagnostic test in infectious diseases area in France and Spain
  2. Working on the development of the health economic model for technology in the breast cancer space in the UK
  3. Working on Evidence Gap Analysis for a neurostimulator in the cardiology field in England, France, Germany, and Italy
  4. Implementing feedback from the client on the policy paper for diabetes technology
  5. Working on the development of a European value dossier for a wound care product
  6. Finalizing the work on Evidence Gap Analysis for imaging technology in cardiology space in Austria, Belgium, England, France, Italy, and the Netherlands
  7. Working on the development of a value dossier for a urinary technology in the EMEA region

Let us know if you need any market access or HEOR support for your medical technology in Europe.